Literature DB >> 17050123

In vitro characterization of binding and stability of single-chain Fv Ni-NTA-liposomes.

Ronny Rüger1, Dafne Müller, Alfred Fahr, Roland E Kontermann.   

Abstract

Recently, we presented a new method for the generation of single-chain Fv (scFv) immunoliposomes, which circumvents the necessity to introduce additional reactive groups in the protein. This method is based on immobilizing scFv fragments via their C-terminal hexahistidyl-tag on liposomes containing nickel-complexed dioleoyl-glycero-succinyl-nitrilotriacetic acid (Ni-NTA-DOGS) as an anchor lipid within the lipid bilayer. Here, we have extended this approach to various other scFv fragments and further demonstrate strong and selective binding of these liposomes to target cells in vitro. In order to evaluate suitability for in vivo applications, we investigated the influence of human plasma on stability and binding behaviour of scFv Ni-NTA-liposomes in vitro using scFv A5 directed against human endoglin (CD105) as a model antibody. We could show that the binding activity to target cells is rapidly lost in the presence of human plasma. Incorporation of polyethylene glycol (PEG) chains into the lipid bilayer did not protect against loss of binding capability. Further studies showed that loss of binding is mainly due to displacement of Ni-NTA-bound scFv fragments caused by plasma proteins. In conclusion, the system allows for a rapid and flexible generation of target cell specific immunoliposomes for in vitro applications but lacks stability for in vivo applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050123     DOI: 10.1080/10611860600864018

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  7 in total

Review 1.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  Core-based lipid nanoparticles as a nanoplatform for delivery of near-infrared fluorescent imaging agents.

Authors:  Nadia Anikeeva; Yuri Sykulev; Edward J Delikatny; Anatoliy V Popov
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

3.  Influence of multivalent nitrilotriacetic acid lipid-ligand affinity on the circulation half-life in mice of a liposome-attached His6-protein.

Authors:  Virginia Platt; Zhaohua Huang; Limin Cao; Matthew Tiffany; Kareen Riviere; Francis C Szoka
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

Review 4.  Designer lipids for drug delivery: from heads to tails.

Authors:  Aditya G Kohli; Paul H Kierstead; Vincent J Venditto; Colin L Walsh; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-06       Impact factor: 9.776

5.  Functionalization of cobalt porphyrin-phospholipid bilayers with his-tagged ligands and antigens.

Authors:  Shuai Shao; Jumin Geng; Hyun Ah Yi; Shobhit Gogia; Sriram Neelamegham; Amy Jacobs; Jonathan F Lovell
Journal:  Nat Chem       Date:  2015-04-20       Impact factor: 24.427

6.  Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.

Authors:  Mesha Saeed; Mandy van Brakel; Sara Zalba; Erik Schooten; Joost A P Rens; Gerben A Koning; Reno Debets; Timo L M Ten Hagen
Journal:  Int J Nanomedicine       Date:  2016-03-08

7.  A malaria vaccine adjuvant based on recombinant antigen binding to liposomes.

Authors:  Wei-Chiao Huang; Bingbing Deng; Cuiyan Lin; Kevin A Carter; Jumin Geng; Aida Razi; Xuedan He; Upendra Chitgupi; Jasmin Federizon; Boyang Sun; Carole A Long; Joaquin Ortega; Sheetij Dutta; C Richter King; Kazutoyo Miura; Shwu-Maan Lee; Jonathan F Lovell
Journal:  Nat Nanotechnol       Date:  2018-10-08       Impact factor: 39.213

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.